Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
about
G-protein-coupled receptor kinases in inflammation and diseaseMechanical allodyniaCommonalities between pain and memory mechanisms and their meaning for understanding chronic painMetformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in MiceExchange protein directly activated by cAMP encoded by the mammalian rapgef3 gene: Structure, function and therapeuticsRecent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).Inhibition of Mitochondrial p53 Accumulation by PFT-μ Prevents Cisplatin-Induced Peripheral Neuropathy.[EXPRESS] Epac and Nociceptor Sensitization.Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 "therapeutic window".Individual differences in acute pain-induced endogenous analgesia predict time to resolution of postoperative pain in the rat.Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism.Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice.Downregulation of Spinal G Protein-Coupled Kinase 2 Abolished the Antiallodynic Effect of ElectroacupunctureGelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice.The pharmacology of nociceptor primingSustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive ActivityCritical role for Epac1 in inflammatory pain controlled by GRK2-mediated phosphorylation of Epac1.Epac-protein kinase C alpha signaling in purinergic P2X3R-mediated hyperalgesia after inflammationEXPRESS: F-actin links Epac-PKC signaling to purinergic P2X3 receptors sensitization in dorsal root ganglia following inflammation.Epac1 interacts with importin β1 and controls neurite outgrowth independently of cAMP and Rap1.Inhibition of Epac1 suppresses mitochondrial fission and reduces neointima formation induced by vascular injury.Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets.A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2.Pro-inflammatory cytokines mediate GPCR dysfunction.Effect of Epac1 on pERK and VEGF Activation in Postoperative Persistent Pain in Rats.SDF1-CXCR4 Signaling Contributes to the Transition from Acute to Chronic Pain State.A cell-based, quantitative and isoform-specific assay for exchange proteins directly activated by cAMP.An Orally Active Epac Inhibitor Reverses Mechanical Allodynia and Loss of Intraepidermal Nerve Fibers \iIn A Mouse Model of Chemotherapy-Induced Peripheral Neuropathy.G Protein-Coupled Receptor Kinases in the Inflammatory Response and Signaling.Identification of FAM173B as a protein methyltransferase promoting chronic pain.Divergent roles of immune cells and their mediators in pain.Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor.PKCβII-induced upregulation of PGP9.5 and VEGF in postoperative persistent pain in rats
P2860
Q26801467-F1650F34-04BF-4739-ABCA-0E78960C44FFQ26861190-6FFC2198-1CEF-4890-8A39-BEAF00CC054FQ28083722-C160DD19-8113-4804-8D97-528F88224AACQ28551025-567AF4AC-4F16-4900-B34A-0CBB61FEAD26Q28608179-F665A872-D119-420D-9311-3B1731CB8AB5Q30405298-3678A546-AABC-42BA-87BD-505133BE1458Q33571709-EC16E492-CB6E-4B53-8D2D-470DCD9D811DQ33866295-B76ACECB-F3EB-4887-8DED-C8C1372F22C8Q34467944-B9924BBC-A4E9-4247-B5DB-757115493A16Q35196289-27DC7F8C-F2A2-4269-B465-9E73258CB989Q35515503-0367368C-E046-4B84-A799-D1F84C318EE9Q35554122-76174EE9-2426-4588-9B4A-B80EC8EB52BBQ35598841-E2786FC3-AB6C-4EDE-AD84-471569D237FDQ36254561-279FAD76-37A1-4234-8134-C8F33A5B8F69Q36332325-0EC3CDE5-6B78-4B33-A9CF-513D7977CD82Q36431999-EF976492-ABDF-4AAB-946C-628124260F40Q36710634-00DBCA74-1CB7-4F38-964B-ADA0BB7C3F99Q37016584-CD8CE465-C0A8-4A77-8CA6-54B8A2EC298DQ37114720-FEDED554-DEF8-4884-9D74-BE4233138A1BQ37390223-6D3D25D8-3782-4AA4-A571-46109A6A4DA2Q37405587-95665D30-5665-4CC1-8E29-13E21C69CC4EQ38747476-B0492D30-ED97-47A8-81F4-7146BF38CC09Q38789599-6D77E54F-465E-409D-861B-F3DB0E8726C1Q39070066-ABF38089-1A49-4C31-B1AA-87E3F11F1ED3Q39692655-D0F77099-3507-4DB7-965B-1A58812D3DD5Q39891334-9EF75305-0FE9-40BD-BCB4-1F34BC155EE8Q41108182-8EEB5BF1-2271-4BC7-B287-B4A6A5C8D3FFQ47549123-B71998B9-DEFE-446F-B766-C83D87E12793Q47740257-E2C2B1AA-69AE-494E-AB02-9D077D580520Q50000807-C9F73E58-1477-4614-9F12-D94A0A5334F2Q50426470-10B45E77-DF97-4786-A5CA-999240D3C4D1Q52656382-9609901B-2EF9-45A4-9AD9-766028F904D5Q55248528-3A607AF2-F5D4-4293-A079-53D314483521Q57491119-EC540EBB-FE76-4B88-8BB8-9D4A6BF40C80
P2860
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
@ast
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
@en
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
@nl
type
label
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
@ast
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
@en
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
@nl
prefLabel
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
@ast
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
@en
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
@nl
P2093
P2860
P356
P1476
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain
@en
P2093
Anil K Sood
Anne Vroon
Annemieke Kavelaars
Cobi J Heijnen
Hanneke L D M Willemen
Huijing Wang
Xinna Zhang
Yoshihiro Ishikawa
P2860
P304
P356
10.1172/JCI66241
P407
P577
2013-11-15T00:00:00Z